These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27362942)

  • 41. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation.
    Chen N; Fang W; Zhan J; Hong S; Tang Y; Kang S; Zhang Y; He X; Zhou T; Qin T; Huang Y; Yi X; Zhang L
    J Thorac Oncol; 2015 Jun; 10(6):910-23. PubMed ID: 25658629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional expression of the voltage-gated Na⁺-channel Nav1.7 is necessary for EGF-mediated invasion in human non-small cell lung cancer cells.
    Campbell TM; Main MJ; Fitzgerald EM
    J Cell Sci; 2013 Nov; 126(Pt 21):4939-49. PubMed ID: 23986482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Possible differential EGFR-TKI efficacy among exon 19 deletional locations in EGFR-mutant non-small cell lung cancer.
    Kaneda T; Hata A; Tomioka H; Tanaka K; Kaji R; Fujita S; Tomii K; Katakami N
    Lung Cancer; 2014 Nov; 86(2):213-8. PubMed ID: 25304185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression.
    Koo T; Yoon AR; Cho HY; Bae S; Yun CO; Kim JS
    Nucleic Acids Res; 2017 Jul; 45(13):7897-7908. PubMed ID: 28575452
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical analysis of NSCLC patients reveals lack of association between EGFR mutation and TET1 downregulation.
    Lai JI; Lai YC; Chen YC; Wang NK; Pan JN; Wang WS; Chang SC
    Cancer Gene Ther; 2017 Sep; 24(9):373-380. PubMed ID: 28776568
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of hsa-miR-6086 protects human umbilical vein endothelial cells against TNFα-induced proliferation inhibition and apoptosis via CDH5.
    Cai X; Zhou X; Xiao F; Ye B; Huang W; Huang Z
    Gene; 2018 Jun; 661():202-208. PubMed ID: 29605606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular imaging of nonsmall cell lung carcinomas expressing active mutant EGFR kinase using PET with [(124)i]-morpholino-IPQA.
    Yeh SH; Lin CF; Kong FL; Wang HE; Hsieh YJ; Gelovani JG; Liu RS
    Biomed Res Int; 2013; 2013():549359. PubMed ID: 23956990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation of E-cadherin gene polymorphisms and epidermal growth factor receptor mutation in lung adenocarcinoma.
    Huang CY; Hsieh MJ; Liu TC; Chiang WL; Liu MC; Yang SF; Tsao TC
    Int J Med Sci; 2018; 15(8):765-770. PubMed ID: 30008585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of Cbl-dependent epidermal growth factor receptor degradation in Ling Zhi-8 suppressed lung cancer.
    Lin TY; Hsu HY; Sun WH; Wu TH; Tsao SM
    Int J Cancer; 2017 Jun; 140(11):2596-2607. PubMed ID: 28198003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cold atmospheric plasma and iron oxide-based magnetic nanoparticles for synergetic lung cancer therapy.
    Li W; Yu H; Ding D; Chen Z; Wang Y; Wang S; Li X; Keidar M; Zhang W
    Free Radic Biol Med; 2019 Jan; 130():71-81. PubMed ID: 30342190
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DNA methylation in lung cancer.
    Toyooka S; Matsuo K; Gazdar AF
    N Engl J Med; 2008 Jun; 358(23):2513; author reply 2514. PubMed ID: 18525051
    [No Abstract]   [Full Text] [Related]  

  • 53. Role and relevance of TrkB mutations and expression in non-small cell lung cancer.
    Harada T; Yatabe Y; Takeshita M; Koga T; Yano T; Wang Y; Giaccone G
    Clin Cancer Res; 2011 May; 17(9):2638-45. PubMed ID: 21242122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. miR-646 is a key negative regulator of EGFR pathway in lung cancer.
    Pan Y; Chen Y; Ma D; Ji Z; Cao F; Chen Z; Ning Y; Bai C
    Exp Lung Res; 2016 Aug; 42(6):286-95. PubMed ID: 27462913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Cdh5-CreERT2 transgene causes conditional Shb gene deletion in hematopoietic cells with consequences for immune cell responses to tumors.
    He Q; Li X; Singh K; Luo Z; Meija-Cordova M; Jamalpour M; Lindahl B; Kriz V; Vuolteenaho R; Ulvmar M; Welsh M
    Sci Rep; 2019 May; 9(1):7548. PubMed ID: 31101877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interaction between CXCR4 and EGFR and downstream PI3K/AKT pathway in lung adenocarcinoma A549 cells and transplanted tumor in nude mice.
    Wu J; Liu Y; Ma Y; Wang R; Ji X; Zhang Y; Du Y
    Int J Clin Exp Pathol; 2020; 13(2):132-141. PubMed ID: 32211093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Label/Quencher-Free Detection of Exon Deletion Mutation in Epidermal Growth Factor Receptor Gene Using G-Quadruplex-Inducing DNA Probe.
    Kim HR; Lee IJ; Kim DE
    J Microbiol Biotechnol; 2017 Jan; 27(1):72-76. PubMed ID: 27794588
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Michelini S; Ricci M; Amato B; Gentileschi S; Veselenyiova D; Kenanoglu S; Fiorentino A; Kurti D; Baglivo M; Manara E; Basha SH; Priya S; Krajcovic J; Dundar M; Belgrado JP; Dautaj A; Bertelli M
    Lymphat Res Biol; 2022 Oct; 20(5):496-506. PubMed ID: 34882481
    [No Abstract]   [Full Text] [Related]  

  • 59. Retraction Note: ANGPTL4 functions as an oncogene through regulation of the ETV5/CDH5/AKT/MMP9 axis to promote angiogenesis in ovarian cancer.
    Liu Y; Yang R; Zhang Y; Zhu Y; Bao W
    J Ovarian Res; 2023 Jan; 16(1):23. PubMed ID: 36698130
    [No Abstract]   [Full Text] [Related]  

  • 60. Targeting the metastatic niche through anti-angiogenic approaches in epidermal growth factor receptor mutant non-small cell lung cancer.
    Tan WL; Tan DSW
    Transl Lung Cancer Res; 2018 Feb; 7(Suppl 1):S13-S18. PubMed ID: 29531897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.